|
|
|||||||||||
SHORT REPORTS |
Department of Psychiatry, University of Oulu and Oulu University Hospital, Oulu, and Academy of Finland, Helsinki
Department of Psychiatry, University of Oulu and Oulu University Hospital, Oulu, Finland
Department of Psychiatry, University of Cambridge, Cambridge, UK
Department of Psychiatry, University of Oulu and Oulu University Hospital
Clinic of Child Psychiatry, University of Oulu and Oulu University Hospital
Institute of Health Sciences, University of Oulu, and Unit of General Practice, Oulu University Hospital, Oulu
Department of Psychiatry, University of Turku, Turku
Social Psychiatry Unit, Tampere School of Public Health, University of Tampere, and Department of Psychiatry, Tampere University Hospital, Tampere
Department of Psychiatry, University of Oulu and Oulu University Hospital, Oulu, and Academy of Finland, Helsinki, Finland
Correspondence: Dr Jouko Miettunen, Department of Psychiatry, University of Oulu, PO Box 5000, 90014 University of Oulu, Finland. Email: jouko.miettunen{at}oulu.fi
None.
Recent interest has focused on the association between cannabis use and risk of psychosis. In the largest unselected, population-based study on this topic to date, we examined cannabis use and prodromal symptoms of psychosis at age 15–16 years among 6330 adolescents. Those who had tried cannabis (n=352; 5.6% of the total sample) were more likely to present three or more prodromal symptoms even after controlling for confounders including previous behavioural symptoms (OR=2.23; 95% CI 1.70–2.94). A dose–response effect was seen. We conclude that cannabis use is associated with prodromal symptoms of psychosis in adolescence.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |